Anti-inflammatory therapies for CVD risk prevention
Ulrich Laufs, MD, PhD
Anti-inflammatory effects of GLP-1RA in T2D
Rein Oostveen, MD
Pro/con debate: Are we ready to treat inflammation for ASCVD prevention?
Paul Ridker, MD
Lukas Hoes, MD
David Conen, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.